Eric Topol, MD
Editor-in-Chief, Medscape

Eric Topol is the Editor in Chief of Medscape Medical News

Voted Most Influential Physician Executive in the US in Modern Healthcare's 2012 poll, Dr. Topol works on genomic and wireless digital innovative technologies to reshape the future of medicine. He is a practicing cardiologist at Scripps in La Jolla, California, and is widely credited for Cleveland Clinic's status as the leading center for heart care. There, he started a medical school, led worldwide clinical trials to advance care for heart disease, and spearheaded the discovery of genes that increase susceptibility for heart attacks.

 

Latest Articles by Eric Topol

About Eric J. Topol

Topol has led the flagship NIH-supported Scripps Translational Science Institute since 2006 and co-founded the West Wireless Health Institute. He is a professor of genomics at The Scripps Research Institute and Chief Academic Officer of Scripps Health. Topol pioneered the development of many routinely used medications, including t-PA, Plavix, Angiomax, and ReoPro; he was the first physician to raise safety concerns about Vioxx. He has published 1100 peer-reviewed articles and over 30 medical textbooks.

In 2009, GQ named Topol one of the 12 "Rock Stars of Science." In 2011, the University of Michigan initiated the Eric Topol Professor of Cardiovascular Medicine. His alma mater, University of Rochester, awarded him its highest honor, the Hutchinson Medal. He was elected to the Institute of Medicine of the National Academy of Sciences and is one of the top 10 most cited researchers in medicine. His book The Creative Destruction of Medicine (Basic Books) was published in 2012.

Eric J. Topol, MD, has disclosed the following relevant financial relationships:

Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Apple; AltheaDX; Biological Dynamics; Dexcom; Edico Genome, GenapSys; Gilead Sciences, Inc.; Google; Illumina, Inc.; Molecular Stethoscope, Myokardia, Quest Diagnostics; Walgreen Company

Received research grant from: National Institutes of Health; Qualcomm Foundation

Сиалис 5 мг